Skip to main content
. Author manuscript; available in PMC: 2024 Dec 1.
Published in final edited form as: Am J Obstet Gynecol MFM. 2023 Oct 22;5(12):101200. doi: 10.1016/j.ajogmf.2023.101200

Table 3.

Primary regression models for composite IS by treatment group

Intent-to-Treat (ITT) Modified Intent-to-Treat (mITT) Median or more visits in the assigned group (M+)
GPNC vs IPNC Unj. Estimate (95% CI) p Adj. Estimate (95% CI) P Unj. Estimate (95% CI) p Adj. Estimate (95% CI) p Unj. Estimate (95% CI) p Adj. Estimate (95% CI) p
Composite IS second trimester −0.05 (−0.60 – 0.50) 0.87 0.04 (−0.53 – 0.61) 0.89 −0.10 (−0.69 – 0.50) 0.75 −0.08 (−0.69 – 0.53) 0.80 −0.09 (−0.80 – 0.61) 0.79 −0.12 (−0.85 – 0.61) 0.75
Composite IS third trimester 0.49 (0.03 – 0.95) 0.04 0.44 (0.03 – 0.84) 0.04 0.51 (0.02 – 1.00) 0.04 0.45 (0.01 – 0.89) 0.04 0.16 (−0.45 – 0.77) 0.61 0.11 (−0.51 – 0.74) 0.72
*

controlled for age, BMI, smoking before pregnancy, GA at blood draw Bolded results indicate p<0.05